CAC (gated) Algorithm vs iPredict Eye Screening

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Bunkerhill Health
VS
by iHealthScreen

AI Verdict

Tool A is specifically designed for the automatic detection and quantification of coronary artery calcium from ECG-gated cardiac CT scans, directly supporting cardiologists and radiologists in assessing coronary artery health. Conversely, Tool B is an AI-powered screening tool primarily for ophthalmological conditions like AMD, DR, and Glaucoma, additionally offering risk prediction for systemic diseases such as stroke and heart attack based on retinal analysis. While both utilize AI and address aspects of cardiovascular health, their primary diagnostic modalities and clinical focus areas are distinct.

Choose CAC (gated) Algorithm if…

Choose the CAC (gated) Algorithm if your cardiology or radiology department requires precise, automated quantification of coronary artery calcium from non-contrast ECG-gated cardiac CT scans. This tool is ideal for integrating into existing cardiac imaging workflows to enhance the assessment of coronary artery health and pre-populate structured reports for physician review.

View CAC (gated) Algorithm →

Choose iPredict Eye Screening if…

Choose iPredict Eye Screening if your primary care clinic, ophthalmology practice, or telemedicine service needs a fast, AI-powered solution for broad screening of multiple retinal diseases, including AMD, DR, and Glaucoma. This tool is particularly well-suited for opportunistic detection of these conditions and providing risk predictions for systemic diseases like stroke and heart attack in a general patient population.

View iPredict Eye Screening →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature CAC (gated) Algorithm iPredict Eye Screening
Pricing Unknown Contact for pricing
Deployment Unknown Cloud-based (Software as a Medical Device), accessible in primary care settings, clinics, hospitals, and online for telemedicine and prediction apps.
FDA Status Yes AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

iPredict Eye Screening

Tool B emphasizes an 'easy to operate, non-invasive, with an advanced touchscreen interface' and fast results (test in <5 min, report in <60 sec), suggesting a highly intuitive and efficient user experience for a broader range of clinical settings. While Tool A integrates into existing radiology workflows, Tool B's description highlights a more direct and universally accessible ease of use, potentially requiring less specialized training for its operation.

Clinical Value

iPredict Eye Screening

Tool B offers screening for multiple critical eye conditions (Diabetic Retinopathy, AMD, Glaucoma) and provides risk prediction for systemic diseases like stroke and heart attack, significantly broadening its clinical impact. Tool A focuses on a single, albeit important, aspect of cardiovascular health (CAC quantification). Tool B's multi-faceted approach to disease screening and risk prediction provides a wider range of clinical benefits.

Pricing & Value

iPredict Eye Screening

Tool B provides an estimated pricing model ('Per patient screening on a Software as a Service (SaaS) model, estimated $10-$20 per patient') which offers more transparency and allows potential customers to better assess value. Tool A only states 'contact for pricing,' making it harder to evaluate its cost-effectiveness upfront.

Enterprise Readiness

CAC (gated) Algorithm

Tool A explicitly states 'has_baa': 'yes' and is 'Part of the broader Carebricks platform for AI-powered workflows,' indicating a more mature and integrated enterprise solution. While Tool B mentions EHR integration, the explicit BAA and platform approach of Tool A suggest a higher level of readiness for large-scale healthcare enterprise deployment and compliance.

Innovation

CAC (gated) Algorithm

Tool A explicitly highlights its use of 'Generative AI for clinical reasoning and action,' which represents a cutting-edge and advanced approach in the AI space. While Tool B is innovative in its multi-disease screening and risk prediction capabilities, it does not specify a particular advanced AI methodology in the same way.

Support & Docs

Tie

Neither the provided structured facts nor readily available web searches offer specific details regarding dedicated customer support channels, comprehensive documentation, or user resources for either Tool A or Tool B. Without this information, it is not possible to differentiate between the two on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature CAC (gated) Algorithm iPredict Eye Screening
Tool Name CAC (gated) Algorithm iPredict Eye Screening
Primary Function Automatically detects and quantifies coronary artery calcium from non-contrast ECG-gated cardiac CT scans, aiding physicians in assessing coronary artery health. AI-powered screening tool for age-related macular degeneration (AMD), Diabetic Retinopathy (DR), and Glaucoma, also providing risk prediction for systemic diseases like stroke and heart attack.
Target Specialties Cardiology, Radiology Family Medicine, Internal Medicine, Ophthalmology
Core Detection/Screening Coronary Artery Calcium (CAC) from non-contrast ECG-gated cardiac CT scans Diabetic Retinopathy (DR), Age-related Macular Degeneration (AMD), and Glaucoma
Additional Functionality Pre-populates structured reports for radiologist review and approval, supports opportunistic detection of cardiovascular disease. Electronic Health Record (EHR) Solutions, AI-Based Telemedicine Service, Online Health Risk Prediction System for Diabetic, Stroke, and Heart Attack patients.

Videos

Demos, reviews, and walkthroughs featuring CAC (gated) Algorithm and iPredict Eye Screening.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The CAC (gated) Algorithm is designed for automatic detection and quantification of coronary artery calcium from non-contrast ECG-gated cardiac CT scans, aiding in assessing coronary artery health for patients aged 30 years and above. iPredict Eye Screening, on the other hand, is an AI-powered screening tool for age-related macular degeneration (AMD) in patients aged 50 years and older, as well as for Diabetic Retinopathy (DR) and Glaucoma, and provides risk prediction for systemic diseases like stroke and heart attack.
The CAC (gated) Algorithm analyzes non-contrast ECG-gated cardiac CT scans to detect and quantify coronary artery calcium. In contrast, iPredict Eye Screening utilizes high-resolution images of the patient's retina, typically captured with a color fundus camera, for its AI-based screening and analysis.
The CAC (gated) Algorithm provides automatic detection, segmentation, and quantification of coronary artery calcium, pre-populating structured reports to aid radiologists in assessing coronary artery health. iPredict Eye Screening delivers fast, automated reports (under 60 seconds) for AMD, DR, and Glaucoma screening, and offers online health risk prediction for systemic diseases, integrating with EHRs to support early detection and referral decisions.
AI Tool Finder
AI-powered search. Results may not be comprehensive.